Skip to content
RecruitingPhase 1 / Phase 2

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout

NCT06814522 · PAT-B · University of California, San Diego

Recruiting
Status
Accepting participants
Phase 1 / Phase 2
Phase
10
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

Through an open-label study involving a small group of UCSD physicians experiencing burnout, the investigators will evaluate the feasibility, safety, and preliminary effectiveness of PAT to reduce burnout symptoms.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Stanford Professional Fulfillment Index (PFI)

    Measured over From enrollment until end of study at 12 week follow-up.

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

21 Years to 70 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: 1. UCSD faculty physician, aged 21-70. Volunteer faculty are not included 2. Meets criteria for physician burnout 3. Experiencing symptoms of burnout for \>6 months 4. Able to complete all required study visits 5. Not previously diagnosed with a serious mental illness (including schizophrenia, bipolar disorder, and severe depression), or substance use disorder as confirmed in clinical interview 6. Not currently taking any psychotropic medications or nonpsychotropic medication that may be associated with serotonin syndrome, such as serotonin reuptake inhibitors (SSRI or SNRI), dextromethorphan, linezolid, tramadol, meperidine Exclusion Criteria: 1. Previous inpatient psychiatric hospitalization(s) 2. Previously diagnosed with a psychotic disorder (schizophrenia, schizoaffective disorder, or other psychotic spectrum disorder), bipolar spectrum disorder, personality disorder (borderline personality disorder, antisocial personality disorder, or other severe personality disorders), any severe psychiatric disorder. 3. Exhibiting elevated suicide risk 4. First degree family history of psychosis or bipolar disorder 5. Prior exposure to psilocybin or other psychedelic compounds in the previous 10 years 6. Currently pregnant, nursing, planning pregnancy, engaging in sexual intercourse without effective contraceptive method in last three months 7. Those who plan to donate sperm within three months following the study. 8. Known cardiovascular disease including history of stroke, myocardial infarction, uncontrolled hypertension, valvular heart disease, tachycardia, elongated QT interval, or clinically significant arrythmia. 9. History of seizure disorder 10. Use of recreational illicit drugs 11. Clinically concerning results from vital signs, ECG, physical examination, or laboratory tests during screening 12. Any other clinically significant illnesses deemed to pose risk for the participant

Where

1 study site

FacilityCityRegionCountry
UC San DiegoSan DiegoCaliforniaUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT06814522 on ClinicalTrials.gov →

Last updated in the registry 2026-07-21. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits